Edition:
United Kingdom

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

132.39USD
19 Oct 2018
Change (% chg)

$-0.31 (-0.23%)
Prev Close
$132.70
Open
$132.95
Day's High
$134.98
Day's Low
$132.21
Volume
620,107
Avg. Vol
412,824
52-wk High
$178.86
52-wk Low
$122.50

Summary

Name Age Since Current Position

John Hammergren

59 2018 Chairman of the Board, Chief Executive Officer

Brian Tyler

52 2018 President, Chief Operating Officer

Britt Vitalone

49 2018 Chief Financial Officer, Executive Vice President

Kathleen McElligott

62 2015 Executive Vice President, Chief Technology Officer, Chief Information Officer

Lori Schechter

56 2014 Executive Vice President, Chief Compliance Officer, General Counsel

Jorge Figueredo

57 2008 Executive Vice President - Human Resources

Paul Julian

62 2004 Executive Vice President, Group President

Bansi Nagji

53 2015 Executive Vice President - Corporate Strategy and Business Development

Sundeep Reddy

46 2018 Senior Vice President, Principal Accounting Officer, Corporate Controller

Edward Mueller

71 2015 Lead Independent Director

Andrew Bryant

68 2008 Independent Director

Dominic Caruso

62 2018 Independent Director

N. Coles

58 2014 Independent Director

M. Christine Jacobs

67 1999 Independent Director

Donald Knauss

67 2014 Independent Director

Marie Knowles

71 2002 Independent Director

Bradley Lerman

62 2018 Independent Director

Susan Salka

53 2014 Independent Director

Craig Mercer

2017 Senior Vice President, Investor Relations

Biographies

Name Description

John Hammergren

Mr. John Harvey Hammergren is Chairman of the Board, Chief Executive Officer of the Company. Mr. Hammergren, age 59, has served as Chairman of the Board since July 2002, and President and Chief Executive Officer of the Company since April 2001. Mr. Hammergren joined the Company in 1996 and held a number of management positions before becoming President and Chief Executive Officer. Mr. Hammergren is the Chairman of the Supervisory Board of McKesson Europe, formerly known as Celesio AG. Additionally, he is currently a member of the Business Council, the Business Roundtable and the Healthcare Leadership Council, as well as the Board of Trustees for the Center for Strategic & International Studies. He has been a director of the Company since July 1999.

Brian Tyler

Mr. Brian S. Tyler, Ph.D. is President, Chief Operating Officer of the Company, effective August 2, 2018. He is currently Chairman of the Management Board of McKesson Europe AG and has served in that role since 2017. Mr. Tyler served as the Company’s President and Chief Operating Officer of McKesson Europe from 2016 to 2017, the Company’s President of North American Pharmaceutical Distribution and Services from 2015 to 2016, and as the Company’s Executive Vice President, Corporate Strategy & Business Development from 2012 to 2015. Mr. Tyler previously served in various other leadership roles in the Company, including as President of U.S. Pharmaceutical, President of McKesson Medical-Surgical, and President of McKesson Specialty Health. Mr. Tyler earned his Bachelor of Arts degree in Economics with high honors from the University of California at Santa Cruz. He earned his Ph.D. and Master of Arts degrees from the University of Chicago, Department of Economics.

Britt Vitalone

Mr. Britt Vitalone has been appointed Chief Financial Officer, Executive Vice President of the Company effective January 1, 2018. He is currently Senior Vice President and Chief Financial Officer of U.S. Pharmaceutical and McKesson Specialty Health, which includes responsibility for all day-to-day financial and accounting operations including long range planning and financial oversight of new strategic initiatives. From 2012 to 2014, Mr. Vitalone served as the Company’s Senior Vice President, Corporate Financial Planning and Analysis and Mergers & Acquisitions Finance with responsibility for the Company’s financial planning, cash flow forecasting, mergers an acquisitions and competitive analysis functions. From 2009 to 2012, he was Senior Vice President and Chief Financial Officer of the Company’s Medical-Surgical business, having joined the Company in 2006 as Vice President, Finance of the same business. Prior to joining the Company, Mr. Vitalone held a variety of financial leadership positions with General Electric Financial Assurance, CarMax, Inc. and Bausch & Lomb Inc. Mr. Vitalone holds a Bachelor of Science degree in accounting from St. John Fisher College and is a certified public accountant.

Kathleen McElligott

Ms. Kathleen D. McElligott is the Executive Vice President, Chief Technology Officer and Chief Information Officer of the Company. As McKesson's CIO, McElligott is responsible for the enterprise business technology strategy, technology governance across the corporation, IT Security and Risk Management, infrastructure operations and service delivery to all McKesson businesses. As CTO, McElligott will guide the overall technology direction for the company's healthcare technology products and provide support and guidance for application development processes companywide. The position serves as a support arm to the management teams within McKesson's technology businesses, working collaboratively with each business to optimize the quality, interoperability, and transparency of McKesson's software development operations. McElligott was hired at Emerson in 2000 as vice president of Information Technology for Emerson Power Transmission. In 2003, she was promoted to vice president of Information Technology for Emerson Industrial Automation, a title she held until her promotion to CIO. Prior to joining Emerson, McElligott spent 22 years with General Electric, holding multiple information systems leadership roles, ultimately becoming CIO of supply chain for GE Aircraft Engines. McElligott received a Bachelor's Degree in Computer Science from Kent State University and a Master's Degree in Business Management from Xavier University.

Lori Schechter

Ms. Lori Ann Schechter is the Executive Vice President, Chief Compliance Officer and General Counsel of the Company. Ms. Schechter has served as associate general counsel of McKesson since 2012. Previously, she was a litigation partner at Morrison & Foerster where she represented clients in complex litigation and investigations and served for four years as chair of the 500-lawyer global litigation department. Schechter was named by the National Law Journal as one of the “Top 50 Female Litigators in the Country.” She received her B.A. from Cornell University in 1983, and her J.D. from Yale Law School in 1987.

Jorge Figueredo

Mr. Jorge L. Figueredo is the Executive Vice President - Human Resources of the Company. He served as Senior Vice President, Human Resources, Dow Jones, Inc. from February 2007 to January 2008. Service with the Company — 9 years.

Paul Julian

Mr. Paul Coleman Julian is the Executive Vice President and Group President of the Company. He served as Senior Vice President from August 1999 to April 2004. Service with the Company – 21 years.

Bansi Nagji

Mr. Bansi Nagji is the Executive Vice President - Corporate Strategy and Business Development of the Company. He is Principal, Deloitte Consulting, LLP and Global Leader, Monitor Deloitte (which was formed by the global merger of Monitor Group with Deloitte) from January 2013 to February 2015; President, Monitor Group from July 2012 to January 2013; Partner, Monitor Group from 2001 to January 2013. Service with the Company — 2 years. Mr. Nagji has more than 20 years of experience working with clients on enterprise-wide growth and innovation challenges in the life sciences and consumer sectors. At Deloitte, he strengthened the company's global reach as the leader of its Global Strategy service line and co-chair of the Global Strategy Governance Committee. A noted expert on innovation, he has authored several articles and papers on the topic. Mr. Nagji has previously served as on the Board of Directors of Deloitte, LLP and several other business and nonprofit boards.

Sundeep Reddy

Mr. Sundeep Reddy is Senior Vice President, Principal Accounting Officer, Corporate Controller of the Company, effective July 25, 2018. He joined McKesson in 2013 as Vice President & Controller, McKesson Technology Solutions, progressing to his current role, where he leads a team focused on global consolidations and reporting, external (SEC) reporting, technical accounting, corporate general ledger and financial applications. Mr. Reddy has no familial relationships or related party transactions with the Company that would require disclosure under Items 401(d) or 404(a) of Regulation S-K in connection with his appointment described above. Mr. Reddy has a Bachelor’s degree in Accounting from Georgia State, an MBA from Emory University and is a CPA.

Edward Mueller

Mr. Edward A. Mueller is the Lead Independent Director of the Company. Mr. Mueller, age 71, retired as Chairman and Chief Executive Officer of Qwest Communications International Inc., a provider of voice, data and video services, in April 2011. He held the position of Chairman and Chief Executive Officer of Qwest Communications International Inc. from August 2007 to April 2011. From January 2003 until July 2006, he served as Chief Executive Officer of Williams-Sonoma, Inc., a provider of specialty products for cooking. Prior to joining Williams-Sonoma, Inc., Mr. Mueller served as President and Chief Executive Officer of Ameritech Corporation, a subsidiary of SBC Communications, Inc., from 2000 to 2002. He was formerly a director of The Clorox Company, CenturyLink, Inc., Williams-Sonoma, Inc. and VeriSign, Inc. Mr. Mueller has been a director of the Company since April 2008 and was elected to the role of Lead Independent Director in July 2013. He was re-elected to an additional two-year term as Lead Independent Director effective July 2017. Mr. Mueller brings to the Board chief executive leadership and business management experience, as well as a strong business acumen and strategic planning expertise. Having worked outside the healthcare industry, he also adds to the mix of experiences and perspectives on our Board that promote a robust, deliberative and decision-making process. While Chairman of the Board of Qwest Communications, Mr. Mueller had a leadership role in corporate governance, which enables him to provide valuable contributions as a member of the Governance Committee of our Board. He also has public company board experience with audit committee service.

Andrew Bryant

Mr. Andrew D. Bryant is an Independent Director of the Company. Mr. Bryant was elected Chairman of the Board of Intel Corporation in May 2012. He was named a director of Intel’s board in July 2011 and served as Vice Chairman of the Board from that time until his election as Chairman. He served as Executive Vice President and Chief Administrative Officer of Intel from October 2007 to July 2011. Mr. Bryant joined Intel in 1981 and held a number of management positions before serving as Intel’s Chief Financial Officer from February 1994 to October 2007. He is also a director of Columbia Sportswear Company. He was formerly a director of Synopsys Inc. Mr. Bryant has been a director of the Company since January 2008. He is Chair of the Compensation Committee and a member of the Finance Committee.

Dominic Caruso

Mr. Dominic J. Caruso is Independent Director of the Company. He is retired as Executive Vice President and Chief Financial Officer of Johnson & Johnson in August 2018, having served in that role since 2007. He previously served in other leadership positions at Johnson & Johnson, including as Senior Vice President of Centocor, Inc. and Vice President of Johnson & Johnson’s Group Finance organization. Mr. Caruso currently serves on the Board of Trustees of The Children’s Hospital of Philadelphia and the Cystic Fibrosis Foundation.

N. Coles

Dr. N. Anthony Coles, Jr. M.D. is an Independent Director of the Company. Dr. Coles, age 58, has served as Chairman and Chief Executive Officer of Yumanity Therapeutics, LLC, a company focused on transforming drug discovery for neurodegenerative diseases, since October 2014. From October 2013 to October 2014, Dr. Coles served as Chairman and CEO of TRATE Enterprises LLC, a privately held company. Dr. Coles served as President, Chief Executive Officer and Chairman of the Board of Onyx Pharmaceuticals, Inc., a biopharmaceutical company, from 2012 until 2013, having served as its President, Chief Executive Officer and a member of its board of directors from 2008 until 2012. Prior to joining Onyx Pharmaceuticals, Inc. in 2008, he was President, Chief Executive Officer and a member of the board of directors of NPS Pharmaceuticals, Inc., a public biopharmaceutical company. Before joining NPS Pharmaceuticals, Inc. in 2005, he served in various leadership positions in the biopharmaceutical and pharmaceutical industries, including at Merck & Co., Inc., Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated. Dr. Coles currently serves as a director of Regeneron Pharmaceuticals, Inc. In addition to having previously served as a director of Onyx Pharmaceuticals, Inc. and NPS Pharmaceuticals, Inc., he was formerly a director of Laboratory Corporation of America Holdings, Campus Crest Communities, Inc. and CRISPR Therapeutics. Dr. Coles has been a director of the Company since April 2014.

M. Christine Jacobs

Ms. M. Christine Jacobs is an Independent Director of the Company since January 1999. Ms. Jacobs, age 67, retired from Theragenics Corporation, a manufacturer of prostate cancer treatment devices and surgical products, in 2013, having served as its Chairman, President and Chief Executive Officer. She held the position of Chairman from 2007 to 2013, and previously from 1998 to 2005. She was Co-Chairman of the Board from 1997 to 1998 and was elected President in 1992 and Chief Executive Officer in 1993. Ms. Jacobs has been a director of the Company since January 1999. Having led a public company within the healthcare industry for over 20 years, Ms. Jacobs brings to our Board significant relevant industry experience and a keen understanding of and strong insight into issues, challenges and opportunities facing the Company, including those related to legislative healthcare initiatives. As Chairman and Chief Executive Officer of Theragenics Corporation, she was at the forefront of her company in regard to the evolving corporate governance environment, which enables her to provide ongoing valuable contributions as a member of the Governance Committee of our Board. Ms. Jacobs served as Co-Chair of the Securities and Exchange Commission (“SEC”) Advisory Committee on Small and Emerging Companies from September 2011 to September 2015, which reflects her leadership and public company experience, including capital formation experience.

Donald Knauss

Mr. Donald R. Knauss is an Independent Director of Mckesson Corporation. Mr. Knauss, age 67, retired from The Clorox Company in 2015, having served as Executive Chairman of the Board from November 2014 until July 2015 and Chairman and Chief Executive Officer from October 2006 until November 2014. He was Executive Vice President of The Coca-Cola Company and President and Chief Operating Officer for Coca-Cola North America from February 2004 until September 2006. Prior to his employment with The Coca-Cola Company, he held various positions in marketing and sales with PepsiCo, Inc. and Procter & Gamble and served as an officer in the United States Marine Corps. He currently serves as a director of the Kellogg Company and Target Corporation. Mr. Knauss also serves as the Chairman of the Board of Trustees for the University of San Diego and is a member of the Economic Advisory Council of the San Francisco Federal Reserve Board. He was formerly a director of URS Corporation. Mr. Knauss has been a director of the Company since October 2014. Mr. Knauss has gained substantial board leadership skills through his chairmanship role at The Clorox Company. He also brings substantial executive experience, including in the roles of Chief Executive Officer, President and Chief Operating Officer, through which he has developed valuable operational insights and strategic and long-term planning capabilities. In addition, Mr. Knauss possesses extensive international business management experience, which provides him with valuable insights into global business strategy. He also possesses extensive retail expertise, which includes experience in the retail pharmacy area. Mr. Knauss also has significant other public company board experience. Having worked outside of the healthcare industry, Mr. Knauss enhances the diverse perspectives on the Board.

Marie Knowles

Ms. Marie L. Knowles is an Independent Director of the Company. Ms. Knowles, age 71, retired from Atlantic Richfield Company in 2000 and was Executive Vice President and Chief Financial Officer from 1996 until 2000. She joined Atlantic Richfield Company in 1972 and held a number financial and operating management positions including President of ARCO Transportation Company from 1993 to 1996. Ms. Knowles is also the Chair of the Independent Trustees Fidelity Fixed Income and Asset Allocation Funds. Ms. Knowles was formerly a director of America West Holdings Corporation, Atlantic Richfield Company, Phelps Dodge Corporation and URS Corporation. She has been a director of the Company since March 2002. Ms. Knowles brings to the Board extensive financial experience gained through her career at Atlantic Richfield Company, including her tenure as Chief Financial Officer. This experience makes her well qualified to serve as Chair of the Company’s Audit Committee and as the audit committee financial expert. This experience also enables Ms. Knowles to provide critical insight into, among other things, the Company’s financial statements, accounting principles and practices, internal control over financial reporting, and risk management processes. Ms. Knowles was named a 2013 Outstanding Director by the San Francisco Business Times and the Silicon Valley Business Journal.

Bradley Lerman

Mr. Bradley E. Lerman is Independent Director of the company. Mr. Lerman, age 61, was named Senior Vice President, General Counsel and Corporate Secretary of Medtronic plc in May of 2014 and serves as a member of its executive committee. In this role, he leads the company’s global legal, government affairs and ethics and compliance functions. Prior to Medtronic plc, Mr. Lerman served as Executive Vice President, General Counsel and Corporate Secretary for the Federal National Mortgage Association (“Fannie Mae”). Previous to Fannie Mae, he served as Senior Vice President, Associate General Counsel and Chief Litigation Counsel for Pfizer. Mr. Lerman also served as a litigation partner at Winston & Strawn LLP in Chicago and as an Assistant U.S. Attorney in the Northern District of Illinois. Mr. Lerman has been a director of the Company since April 2018. Mr. Lerman brings to our Board significant legal and regulatory expertise gained from years of large law firm practice and in-house experience, as well as major governmental positions with law enforcement responsibilities. His legal experience and seasoned judgment are instrumental in helping the Board navigate legal challenges. Mr. Lerman’s deep understanding of the healthcare industry and experience linking compliance and legal considerations with corporate strategy also bring valuable insights to our Board.

Susan Salka

Ms. Susan R. Salka is an Independent Director of the Company. Ms. Salka, age 53, has served as Chief Executive Officer and President of AMN Healthcare Services, Inc., the leader in providing healthcare workforce solutions and staffing services to healthcare facilities across the nation, since 2005, and a director of the company since 2003. She has served in several other executive roles since joining AMN Healthcare Services, Inc. in 1990, including Chief Operating Officer, Chief Financial Officer and Senior Vice President of Business Development. She was formerly a director of Beckman Coulter Inc. and Playtex Products. Ms. Salka has been a director of the Company since October 2014. With over 30 years of experience in the healthcare services industry, Ms. Salka brings to the Board a deep understanding of emerging trends in healthcare services. This industry experience gives her insight into important aspects of the Company’s businesses, including opportunities potentially available to those businesses. She has also served in a number of executive leadership positions, including as a Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, which have provided her with business management, operational, financial and long-range planning experience. Ms. Salka also brings valuable experience acquired through significant public company board service.

Craig Mercer

Basic Compensation